We bring this article to you in the public interest and by courtesy of The Lancet's open distribtion policy. See end for information on reuse. (Source: The Lancet, UK;s top medical magazine)
It's a long artiicle and quite techmical but iot has to be in order to explain properly how the oublic have been misled by government and corporate propaganda.
If you are not into long reads and heavy medical; detail we suggest you scroll to the paragraph beginning Vaccine efficiency is generally reported ... immediately below the first graphic.
For inormation on reusing this article see the lines on copyright details at the bottom of the article and references and above the LINKS section of our page.
- Supplementary appendix
- 1.Covid-19 Vaccine Tracker.https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.htmlDate accessed: March 10, 2021
- 2.Safety and efficacy of the BNT162b2 mRNA COVID-19 Vaccine.N Engl J Med. 2020; 383: 2603-2615
- 3.Efficacy and safety of the mRNA-1273 SARS-CoV-2 Vaccine.N Engl J Med. 2021; 384: 403-416
- 4.Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.Lancet. 2021; 397: 99-111
- 5.Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.Lancet. 2021; 397: 671-681
- 6.Vaccines and Related Biological Products Advisory Committee meeting: FDA briefing document.https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-december-10-2020-meeting-announcementDate: Dec 10, 2020Date accessed: March 10, 2021
- 7.Vaccines and Related Biological Products Advisory Committee meeting: FDA briefing document.https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-december-17-2020-meeting-announcementDate: Dec 17, 2020Date accessed: March 10, 2021
- 8.Vaccines and Related Biological Products Advisory Committee meeting: FDA briefing document.https://www.fda.gov/advisory-committees/advisory-committee-calendar/vaccines-and-related-biological-products-advisory-committee-february-26-2021-meeting-announcementDate: Feb 26, 2021Date accessed: March 10, 2021
- 9.What does 95% COVID-19 vaccine efficacy really mean?.Lancet Infect Dis. 2021; (published online Feb 17.)
- 10.Outcome reporting bias in COVID-19 mRNA vaccine clinical trials.Medicina (Kaunas). 2021; 57: 199
- 11.BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting.N Engl J Med. 2021; (published online Feb 24.)